Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy

作者:Yukai Huang, Wei‐Chung Cheng, Ting-Ting Kuo, Juan‐Cheng Yang, Yang‐Chang Wu, Heng‐Hsiung Wu, Chia-Chien Lo, Chih-Ying Hsieh, Sze‐Ching Wong, Chih‐Hao Lu, Wan-Ling Wu, Shih‐Jen Liu, Yi‐Chuan Li, Ching‐Chan Lin, Chia‐Ning Shen, Mien‐Chie Hung, Jaw‐Town Lin, Chun‐Chieh Yeh, Yuh‐Pyng Sher · 发表于:Nature Cancer · 年份:2024 · DOI:10.1038/s43018-023-00720-x · 被引用次数:35 · 研究领域:Signaling Pathways in Disease、Peptidase Inhibition and Analysis、Protease and Inhibitor Mechanisms